Immuno-Biological Laboratories
4570.TPharmaceutical
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Tsutomu Seito | 12.06% |
Each holder's own ratio from its most recent large-shareholding report.
Ownership history · 12
| Holder | Ratio | Change |
|---|---|---|
| Tsutomu Seito2026-09-30 | 12.06% | no change |
| Tsutomu Seito2026-09-30 | 12.06% | no change |
| Tsutomu Seito2026-09-30 | 12.06% | no change |
| Tsutomu Seito2026-09-30 | 12.06% | -0.82pp |
| Tsutomu Seito2026-09-30 | 12.88% | no change |
| Tsutomu Seito2026-09-30 | 12.88% | -0.47pp |
| Tsutomu Seito2026-09-30 | 13.35% | -0.13pp |
| Tsutomu Seito2026-09-30 | 13.48% | no change |
| Tsutomu Seito2026-09-30 | 13.48% | -1.67pp |
| Tsutomu Seito2026-09-30 | 15.15% | no change |
| Tsutomu Seito2026-09-30 | 15.15% | -0.17pp |
| Tsutomu Seito2026-09-30 | 15.32% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.